Target intelligence / Profile preview

Dendritic cell endocytic machinery

Molecular classification
C-type lectin receptor, Fc receptor, Scavenger receptor, Receptor
01

Overview

The dendritic cell (DC) endocytic machinery is a specialized system of surface receptors and intracellular pathways responsible for the capture, internalization, and processing of antigens. This machinery primarily consists of C-type lectin receptors (CLRs) such as DEC-205 (CD205), DC-SIGN (CD209), and the mannose receptor (CD206), as well as Fc receptors and scavenger receptors (2.1.2, 2.2.4). These components facilitate various forms of uptake, including receptor-mediated endocytosis, macropinocytosis, and phagocytosis, allowing DCs to sample their environment for pathogens and debris (2.2.3). Once internalized, antigens are routed to specialized endosomal and lysosomal compartments where they are processed into peptides and loaded onto MHC class I and II molecules for presentation to T cells (2.2.5). In therapeutic development, this machinery is targeted to enhance the efficacy of vaccines and immunotherapies; by conjugating antigens to ligands or antibodies specific for these receptors, researchers can ensure efficient antigen delivery to DCs to elicit potent, antigen-specific T-cell responses (2.1.1, 2.1.4). However, targeting this system requires careful co-administration of adjuvants to prevent the induction of immune tolerance rather than activation (2.1.2).

Other names
Dendritic cell endocytic receptorsDC antigen uptake machineryDC endocytosis systemAntigen uptake machinery
02

Mechanism of action

Targeted delivery of antigens to dendritic cells via receptor-mediated endocytosis to promote antigen processing and T-cell activation.

03

Biological functions

Immune responseAntigen processing and presentationEndocytosisSignal transduction
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Induction of immune tolerance in the absence of adjuvantsOff-target uptake by non-DC populations (e.g., macrophages)Potential for cytokine release syndromeAnti-drug antibody (ADA) formation against targeting vehicles
06

Interacting drugs

CDX-1401

3 more in the full profile.

07

Biomarkers

DEC-205 (LY75)DC-SIGN (CD209)Mannose receptor (CD206)CD11c (ITGAX)

Beyond the preview

Go deeper on Dendritic cell endocytic machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell endocytic machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call